The US Food and Drug Administration (FDA) has granted breakthrough device designation for Acrivon Therapeutics’ ACR-368 ...
The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...
The update comes about six weeks after an early alert flagged reports of 120 injuries and one death linked to reprocessing of ...
The FDA today issued an alert around a safety concern regarding diabetes devices that rely on smartphones to deliver critical safety alerts.
Some food labels designed to nudge Americans toward healthier food choices can have the opposite effect, new University of ...
Earlier this month, the U.S. Food and Drug Administration proposed food companies use new, front-of-package labels highlighting the levels of fat, salt and added sugar in their products.
The ACR-368-tailored OncoSignature assay is being used to identify patients most likely to respond to the company's lead drug candidate ACR-368 in an ongoing, registrational-intent, phase IIb trial in ...
Acrivon Therapeutics said the Food and Drug Administration has granted Breakthrough Device designation for its ACR-368 OncoSignature assay, an immunofluorescence assay for the identification of ...
The update comes about six weeks after an early alert flagged reports of 120 injuries and one death linked to reprocessing of the device.